Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Optimal design for dose response using beta distributed responses.

Yuehui Wu1, Valerii V Fedorov, Kathleen J Propert

  • 1Biomedical Data Sciences, GlaxoSmithKline, Collegeville, Pennsylvania 1926-0989, USA. Yuehui.2.Wu@gsk.com

Journal of Biopharmaceutical Statistics
|August 5, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

GABRG2 mutations in genetic epilepsy with febrile seizures plus: structure, roles, and molecular genetics.

Journal of translational medicine·2024
Same author

Alterations in brain network functional connectivity and topological properties in DRE patients.

Frontiers in neurology·2023
Same author

Analysis of sodium phenylbutyrate and taurursodiol survival effect in ALS using external controls.

Annals of clinical and translational neurology·2023
Same author

Brain functional connectivity and network characteristics changes after vagus nerve stimulation in patients with refractory epilepsy.

Translational neuroscience·2023
Same author

Urban heat vulnerability: A dynamic assessment using multi-source data in coastal metropolis of Southeast China.

Frontiers in public health·2022
Same author

A Survey of Implementation of ABCDE Protocols.

Journal of intensive care medicine·2022
Same journal

Correction.

Journal of biopharmaceutical statistics·2026
Same journal

Leveraging external controls in clinical trials: estimands, estimation, assumptions.

Journal of biopharmaceutical statistics·2026
Same journal

Special issue of nonclinical statistics in regulatory applications guest editors' notes.

Journal of biopharmaceutical statistics·2026
Same journal

Comparison of flexible parametric modeling and nonparametric methods to estimate restricted mean survival time: A simulation study.

Journal of biopharmaceutical statistics·2026
Same journal

Simulated treatment comparisons with jackknife pseudo values for estimating population-adjusted marginal treatment effects.

Journal of biopharmaceutical statistics·2026
Same journal

Sample sizes for randomized controlled trials utilizing Bayesian response adaptive randomization for continuous outcomes.

Journal of biopharmaceutical statistics·2026
See all related articles

This study introduces beta regression models for analyzing continuous or ordinal data in clinical trials. It develops optimal designs for these models, enhancing the efficiency and interpretability of trial results.

Area of Science:

  • Biostatistics
  • Clinical Trial Design
  • Statistical Modeling

Background:

  • The beta distribution is suitable for modeling responses within a finite interval, such as visual analog scales.
  • Beta regression models link distribution parameters to covariates like dose in clinical trials.
  • Existing models for ordinal data can be complex and difficult to interpret.

Purpose of the Study:

  • To explore locally optimal designs for beta regression models.
  • To focus on D-optimality, minimizing the generalized variance of maximum likelihood estimators.
  • To provide a parsimonious approach for analyzing continuous and ordinal data in clinical trials.

Main Methods:

  • Utilizing a beta regression framework to model bounded responses.
  • Employing locally optimal design criteria, specifically D-optimality.

Related Experiment Videos

  • Using a candidate points searching algorithm to examine optimal designs and model misspecification sensitivity.

    • Main Results:

    • Locally optimal designs were developed for beta regression models.
    • The sensitivity of these designs to model parameter misspecification was assessed.
    • The beta regression model demonstrated utility as a parsimonious approximation for ordinal data.

    Conclusions:

    • Beta regression models offer a flexible and interpretable approach for clinical trial data analysis.
    • The proposed optimal designs enhance the efficiency of parameter estimation.
    • These methods provide a simpler alternative to complex models for ordered categorical outcomes.